We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

LDC and Qurient Close License Agreement on Novel Anti-cancer Compound

News   Jun 04, 2015

 
LDC and Qurient Close License Agreement on Novel Anti-cancer Compound
 
 
 

RELATED ARTICLES

Promising Target in Fight Against Bacteria

News

The aminoacyl-tRNA site (A-site) of the 16S RNA decoding region in the bacterial ribosome looks promising for a new era of antibiotic drug development.

READ MORE

Plant Compound Has Therapeutic Effect on Complications from Snakebites

News

Researchers have found that rutin, an inexpensive, plant-based compound may protect envenomed mice from bleeding and inflammation problems, according to a study published in PLOS Neglected Tropical Diseases

READ MORE

Obesity Linked to Increased Risk of Early-Onset Colorectal Cancer

News

Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE